Skip to main content

The Sjögren’s Foundation is dedicated to the safety of Sjögren’s patients and providing you with the information you need to make decisions. Yesterday, the Centers for Disease Control and Prevention (CDC) and U.S. Food & Drug Administration (FDA) made an announcement warning consumers about the contamination of Delsam Pharma’s Artificial Eye Ointment, in addition to the earlier warnings about the contamination to EzriCare and Delsam Pharma’s artificial tear products.

FDA Risk Statement: Use of contaminated artificial tears can result in the risk of eye infections that could result in blindness.

The CDC and FDA are recommending the public stop using over-the-counter Delsam Pharma’s Artificial Eye Ointment. According to a statement released Tuesday, February 21, 2023 the CDC and FDA warned consumers and health care professionals not to purchase or use Delsam Pharma’s Artificial Eye Ointment due to potential bacterial contamination. On Wednesday, February 22, 2023, the FDA recommended a recall for this product and the company agreed.

Click Here to view the February 21st CDC Statement and Updates

Click Here to view the February 22nd FDA Updates

On January 20, 2023, the CDC and American Academy of Ophthalmology (AAO) recommended that consumers stop using  over-the-counter EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears due to potential bacterial contamination. Click Here to view our January 25th Article for more information

You can report adverse effects of using these products to the FDA and receive instructions on the recall in this article: Click here to review recall information

If you have recently used these products, please contact your eyecare provider to discuss the best course of action for you.